SAPADUR

Serial Number 79244591
Registration 5816080
700

Registration Progress

Application Filed
Aug 28, 2018
Under Examination
Approved for Publication
May 14, 2019
Published for Opposition
May 14, 2019
Registered
Jul 30, 2019

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190730) (Grace Period Filing)
Due: Jan 30, 2026 Grace Period - 11 days
Original deadline was Jul 30, 2025 (overdue)

Trademark Image

SAPADUR

Basic Information

Serial Number
79244591
Registration Number
5816080
Filing Date
August 28, 2018
Registration Date
July 30, 2019
Published for Opposition
May 14, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 30, 2019
Registration
Registered
Classes
005

Rights Holder

Cyclacel Limited

99
Address
Dundee Technopole,
James Lindsay Place Dundee, Tayside DD15JJ
GB

Ownership History

Cyclacel Limited

Original Applicant
99
GB

Cyclacel Limited

Owner at Publication
99
GB

Cyclacel Limited

Original Registrant
99
GB

Legal Representation

Attorney
Jeffrey Smith

USPTO Deadlines

Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190730)
Due Date
July 30, 2025
Grace Period Ends
January 30, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Nov 14, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jul 30, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
May 24, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Dec 13, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 21, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 21, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Oct 30, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 30, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 18, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
May 14, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 14, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 1, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 1, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Apr 24, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 4, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 4, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 4, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 3, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 29, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 25, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 8, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 8, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 21, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 20, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 11, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 13, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 7, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 1, 2018 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical substances and preparations for the treatment of cancer, haematological disorders; pharmaceutical substances and preparations for use in oncology, haematology; medical preparations for the treatment of cancer and haematological disorders, medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and haematological disorders, medical substances in the nature of pharmaceuticals for the treatment of cancer and haematological disorders and preparations for human use for the treatment of cancer and haematological disorders; reagents and diagnostic substances for medical purposes; reagents and diagnostic substances for human medical purposes

Classification

International Classes
005